FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:1037-1043 April 20, 1989 Number 16 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Both n-3 and n-6 polyunsaturated fats have been suggested to lower blood pressure, an effect ascribed to altered biosynthesis of eicosanoids. To test these hypotheses, we studied blood pressure and eicosanoid production during supplementation of dietary fat for four weeks in 32 men with mild essential hypertension. Supplementation was preceded and followed by four-week run-in and recovery periods. Groups of eight subjects received either 10 ml or 50 ml of fish oil (3 or 15 g of n-3 fatty acids) daily, 50 ml of safflower oil (39 g of n-6 fatty acids), or 50 ml of a mixture of oils that approximated the types of fat present in the American diet. The biosynthesis of eicosanoids was assessed by the measurement of urinary metabolites. Blood pressure decreased in the men who received the high dose of fish oil (systolic pressure by a mean of 6.5 mm Hg [P less than 0.03] and diastolic pressure by 4.4 mm Hg [P less than 0.015]), but not in the other groups. Although the formation of vasodilatory prostacyclins (prostaglandins I2 and I3) increased initially, this increase was not maintained as blood pressure fell. The level of thromboxane A2 metabolites fell; metabolites of thromboxane A3 were detected in the groups receiving fish oil. The formation of prostaglandin E2 increased during supplementation with safflower oil and tended to decrease with fish oil; no prostaglandin E3 metabolite was detected. Our data indicate that high doses of fish oil can reduce blood pressure in men with essential hypertension. However, the clinical usefulness and safety of fish oil in the treatment of hypertension will require further study.

Source Information

Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN 37232.

This article has been cited by other articles:

• Song, W.-L., Lawson, J. A., Reilly, D., Rokach, J., Chang, C.-T., Giasson, B., FitzGerald, G. A. (2008). Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid. J. Biol. Chem. 283: 6-16 [Abstract] [Full Text]  
• Lawson, J. A., Kim, S., Powell, W. S., FitzGerald, G. A., Rokach, J. (2006). Oxidized derivatives of {omega}-3 fatty acids: identification of IPF3{alpha}-VI in human urine. J. Lipid Res. 47: 2515-2524 [Abstract] [Full Text]  
• Miura, K., Greenland, P., Stamler, J., Liu, K., Daviglus, M. L., Nakagawa, H. (2004). Relation of Vegetable, Fruit, and Meat Intake to 7-Year Blood Pressure Change in Middle-aged Men: The Chicago Western Electric Study. Am J Epidemiol 159: 572-580 [Abstract] [Full Text]  
• Engler, M. M., Engler, M. B., Pierson, D. M., Molteni, L. B., Molteni, A. (2003). Effects of Docosahexaenoic Acid on Vascular Pathology and Reactivity in Hypertension. Exp. Biol. Med. 228: 299-307 [Abstract] [Full Text]  
• Ye, D., Zhang, D., Oltman, C., Dellsperger, K., Lee, H.-C., VanRollins, M. (2002). Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels. J. Pharmacol. Exp. Ther. 303: 768-776 [Abstract] [Full Text]  
• Iso, H., Sato, S., Umemura, U., Kudo, M., Koike, K., Kitamura, A., Imano, H., Okamura, T., Naito, Y., Shimamoto, T. (2002). Linoleic Acid, Other Fatty Acids, and the Risk of Stroke. Stroke 33: 2086-2093 [Abstract] [Full Text]  
• Leeson, C.P.M, Mann, A, Kattenhorn, M, Deanfield, J.E, Lucas, A, Muller, D.P.R (2002). Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood. Eur Heart J 23: 216-222 [Abstract] [Full Text]  
• De Caterina, R., Basta, G. (2001). n-3 Fatty acids and the inflammatory response -- biological background. Eur Heart J Suppl 3: D42-D49 [Abstract]  
• Holm, T, Andreassen, A.K, Aukrust, P, Andersen, K, Geiran, O.R, Kjekshus, J, Simonsen, S, Gullestad, L (2001). Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J 22: 428-436 [Abstract]  
• Iso, H., Rexrode, K. M., Stampfer, M. J., Manson, J. E., Colditz, G. A., Speizer, F. E., Hennekens, C. H., Willett, W. C. (2001). Intake of Fish and Omega-3 Fatty Acids and Risk of Stroke in Women. JAMA 285: 304-312 [Abstract] [Full Text]  
• Diep, Q. N., Touyz, R. M., Schiffrin, E. L. (2000). Docosahexaenoic Acid, a Peroxisome Proliferator-Activated Receptor-{alpha} Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein Kinase. Hypertension 36: 851-855 [Abstract] [Full Text]  
• Engler, M. B., Engler, M. M. (2000). Docosahexaenoic Acid-Induced Vasorelaxation in Hypertensive Rats: Mechanisms of Action. Biol Res Nurs 2: 85-95 [Abstract]  
• Ferrara, L. A., Raimondi, A. S., d'Episcopo, L., Guida, L., Dello Russo, A., Marotta, T. (2000). Olive Oil and Reduced Need for Antihypertensive Medications. Arch Intern Med 160: 837-842 [Abstract] [Full Text]  
• von Schacky, C. (2000). n-3 Fatty acids and the prevention of coronary atherosclerosis1. Am. J. Clin. Nutr. 71: 224S-227S [Abstract] [Full Text]  
• Burns, C. P., Halabi, S., Clamon, G. H., Hars, V., Wagner, B. A., Hohl, R. J., Lester, E., Kirshner, J. J., Vinciguerra, V., Paskett, E. (1999). Phase I Clinical Study of Fish Oil Fatty Acid Capsules for Patients with Cancer Cachexia: Cancer and Leukemia Group B Study 9473. Clin. Cancer Res. 5: 3942-3947 [Abstract] [Full Text]  
• Mori, T. A, Bao, D. Q, Burke, V., Puddey, I. B, Watts, G. F, Beilin, L. J (1999). Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am. J. Clin. Nutr. 70: 817-825 [Abstract] [Full Text]  
• Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., Beilin, L. J. (1999). Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans. Hypertension 34: 253-260 [Abstract] [Full Text]  
• Hashimoto, M., Shinozuka, K., Gamoh, S., Tanabe, Y., Hossain, M. S., Kwon, Y. M., Hata, N., Misawa, Y., Kunitomo, M., Masumura, S. (1999). The Hypotensive Effect of Docosahexaenoic Acid Is Associated with the Enhanced Release of ATP from the Caudal Artery of Aged Rats. J. Nutr. 129: 70-76 [Abstract] [Full Text]  
• Bao, D. Q., Mori, T. A., Burke, V., Puddey, I. B., Beilin, L. J. (1998). Effects of Dietary Fish and Weight Reduction on Ambulatory Blood Pressure in Overweight Hypertensives. Hypertension 32: 710-717 [Abstract] [Full Text]  
• Williard, D. E., Kaduce, T. L., Harmon, S. D., Spector, A. A. (1998). Conversion of eicosapentaenoic acid to chain-shortened omega–3 fatty acid metabolites by peroxisomal oxidation. J. Lipid Res. 39: 978-986 [Abstract] [Full Text]  
• Toft, I., Bonaa, K. H., Ingebretsen, O. C., Nordoy, A., Jenssen, T. (1997). Fibrinolytic Function After Dietary Supplementation With {omega}3 Polyunsaturated Fatty Acids. Arterioscler. Thromb. Vasc. Bio. 17: 814-819 [Abstract] [Full Text]  
• Toft, I., Bonaa, K. H., Ingebretsen, O. C., Nordoy, A., Jenssen, T. (1995). Effects of n-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension: A Randomized, Controlled Trial. ANN INTERN MED 123: 911-918 [Abstract] [Full Text]